Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Body Weight » Body Weight Changes » Weight Loss » Cachexia
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Body Weight » Thinness » Cachexia
Description
General ill health, malnutrition, and weight loss, usually associated with chronic disease. MeSH
Hierarchy View
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (3)
Phase 2 Indicated Drugs (21)
Other Experimental Indicated Drugs (20)
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (33)
Innovative Medical Research of South Florida, Inc
International Center for Diarrheal Disease Research
Organization Involved with Phase 2 Indications (73)
Gatot Subroto Central Army Hospital
National Center for Complementary and Integrative Health (NCCIH)
National Cheng Kung University
National Institute of Allergy and Infectious Diseases (NIAID)
Oxford Pharmaceutical Resources, Inc.
Roy Castle Lung Cancer Foundation
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (28)
All India Institute of Medical Sciences
Cancer Treatment Centers of America
Malteser Krankenhaus Seliger Gerhardt
Medical University of South Carolina
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.